This document provides administration instructions for the Pfizer Comirnaty bivalent COVID-19 vaccine (Wild Type/Omicron BA.1 or BA.4-5) for booster doses…
This is an instruction manual for the Pfizer Comirnaty bivalent mRNA vaccine, intended as a booster dose for individuals who have completed their primary vaccination series. The document outlines eligibility criteria, including age groups and health conditions, and specifies that it is not for initial vaccination.
The guide details the administration method (intramuscular injection of 0.3ml), contraindications such as severe allergic reactions or fever, and precautions for specific populations like pregnant women or those with bleeding disorders. It also lists potential adverse reactions ranging from common symptoms like pain at the injection site to rare serious conditions. This manual is written in Chinese.
Eligible groups include people aged 65 and over, those aged 12 to 64 with underlying diseases or high risk of deterioration, and healthcare workers.
The recommended dose is one injection of 0.3ml.
No, this vaccine cannot be used for the first dose of vaccination.
Main symptoms include pain at the injection site, headache, joint and muscle pain, fatigue, chills, and fever.